Wu Wei-Miao, Wang Yingying, Jiang Hui-Ru, Yang Chen, Li Xiao-Qiang, Yan Bei, Zhou Yi, Xu Wang-Hong, Lin Tao
Fudan University School of Public Health, Key Lab of Health Technology Assessment, National Health Commission of the People's Republic of China (Fudan University), Shanghai, China.
Fudan University Pudong Institute of Preventive Medicine, Pudong New Area, Shanghai, China.
Front Oncol. 2019 Jun 4;9:399. doi: 10.3389/fonc.2019.00399. eCollection 2019.
Parallel test of risk stratification and two-sample qualitative fecal immunochemical tests (FITs) are used to screen colorectal cancer (CRC) in Shanghai, China. This study was designed to identify an optimal initial screening modality based on available data. A total of 538,278 eligible residents participated in the program during the period of January 2013 to June 2017. Incident CRC was collected through program reporting system and by record linkage with the Shanghai Cancer Registry up to December 2017. Logistic regression model was applied to identify significant factors to calculate risk score for CRC. Cutoff points of risk score were determined based on Youden index and defined specificity. Sensitivity, specificity, and positive predictive values (PPVs) were computed to evaluate validity of assumed screening modalities. A total of 446 CRC were screen-detected, and 777 interval or missed cases were identified through record linkage. The risk score system had an optimal cutoff point of 19 and performed better in detecting CRC and predicting long-term CRC risk than did the risk stratification. When using a cutoff point of 24, parallel test of risk score, and FIT were expected to avoid 56 interval CRCs with minimal decrease in PPV and increase in colonoscopy. However, the observed detection rates were much lower than those expected due to low compliance to colonoscopy. Risk score is superior to risk stratification used in the program, particularly when combined with FIT. Compliance to colonoscopy should be improved to guarantee the effectiveness of CRC screening in the population.
在中国上海,风险分层平行试验和两样本定性粪便免疫化学检测(FIT)被用于筛查结直肠癌(CRC)。本研究旨在根据现有数据确定一种最佳的初始筛查方式。在2013年1月至2017年6月期间,共有538,278名符合条件的居民参与了该项目。通过项目报告系统并与上海癌症登记处进行记录链接,收集截至2017年12月的新发CRC病例。应用逻辑回归模型确定计算CRC风险评分的显著因素。根据约登指数和定义的特异性确定风险评分的截断点。计算敏感性、特异性和阳性预测值(PPV)以评估假定筛查方式的有效性。共筛查出446例CRC,通过记录链接确定了777例间隔期或漏诊病例。风险评分系统的最佳截断点为19,在检测CRC和预测长期CRC风险方面比风险分层表现更好。当使用截断点24时,风险评分与FIT的平行试验预计可避免56例间隔期CRC,同时PPV的降低和结肠镜检查的增加最小。然而,由于结肠镜检查的依从性低,观察到的检测率远低于预期。风险评分优于该项目中使用的风险分层,特别是与FIT联合使用时。应提高结肠镜检查的依从性,以确保人群中CRC筛查的有效性。